Our study also shows that the immune-related interferon, IFN-γ, and IL-6-JAK-STAT3 signaling pathways were all activated in PBRM1MUT ccRCC tumor tissues (Figure 8C). The gene discussed is IL6; the disease is nonpapillary renal cell carcinoma.